Heavy consumption of cocaine has created a tremendous amount of morbidity and mortality, with the US having spent billions of dollars domestically and internationally trying to reduce its availability.
In the late-2000s, there was an unprecedented decline in the US cocaine market: RAND estimated that the total consumption of pure cocaine decreased by roughly 50% from 2006 to 2010. Concurrently, the purity-adjusted price increased by more than 40% at the retail level.
Despite the size and the swiftness of the consumption decrease, there is no consensus about which policies or factors are responsible for the drop.
This essay briefly explores twelve hypotheses for the decline which are neither exhaustive nor mutually exclusive. It pays special attention to the period immediately preceding the consumption decrease, noting that there was a 40% decline in the purity-adjusted retail price from 2000 to 2006. Whether this price decrease was simply part of a larger trend, attributable to policy decisions, a random fluctuation or something else, has yet to be determined.
If further research suggests that much of the consumption drop in the US is attributable to supply-side polices, this does not mean that supply reduction is the optimal approach for reducing problem consumption; much depends on the particular drug, stage of the epidemic, characteristics of the country and the perspective of the decision maker. It would, however, challenge the conventional wisdom that supply-side interventions can do little to influence mature consumption markets.
This publication is part of the RAND external publication series. Many RAND studies are published in peer-reviewed scholarly journals, as chapters in commercial books, or as documents published by other organizations.
RAND is a nonprofit institution that helps improve policy and decisionmaking through research and analysis. RAND's publications do not necessarily reflect the opinions of its research clients and sponsors.